We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardioprotection: The Role of β-Blocker Therapy.
- Authors
Egan, Brent M.; Basile, Jan; Chilton, Robert J.; Cohen, Jerome D.; Vidt, Donald G.
- Abstract
Randomized controlled clinical trials document that β blockers reduce cardiovascular morbidity and mortality, particularly sudden death, in patients with hypertension, heart failure, and post-myocardial infarction. The benefits of β blockers extend across the boundaries of age, gender, and ethnicity, and include diabetic patients with heart failure and/or previous myocardial infarction. Unfortunately, β blockers remain underutilized in many high-risk patients who would likely benefit from their use. This paper reviews the protective role of β blockade in the primary and secondary prevention of cardiovascular events and examines some of the potential barriers to appropriate β blocker use in patients with compelling indications.
- Subjects
CARDIOVASCULAR diseases; HYPERTENSION; DIABETES; MYOCARDIAL infarction; HEART failure
- Publication
Journal of Clinical Hypertension, 2005, Vol 7, Issue 7, p409
- ISSN
1524-6175
- Publication type
Article
- DOI
10.1111/j.1524-6175.2005.04486.x